Nedocromil

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H17NO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0B535E0BN0, chemically known as 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid but generally known as nedocromil, which bears US NIH Compound Identifier 50294. European Medicines Agency schedules Nedocromil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09179MIG. The term NEDOCROMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules nedocromil in its Anatomical Therapeutic Chemical (ATC) Classification. NEDOCROMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nedocromil under HS 29349990 and SITC 51579. As of Q4 2014, NEDOCROMIL remains the US FDA Preferred Term for this commodity. Nedocromil bears US NLM identifiers UMLS ID C0068483 and NCI Concept Code C66225. SMILES: O1C2C(C3N(CC)C(CC(=O)C3CC2C(=O)CC1C(=O)O)C(=O)O)CCC.